Psoriatic Spondyloarthritis Burden is Similar to Ankylosing Spondylitis
Psoriatic spondyloarthritis forms part of the spondyloarthritis spectrum, between peripheral-only psoriatic arthritis and ankylosing spondylitis.
MEASURE 1 Favors Secukinumab for Ankylosing Spondylitis
Secukinumab relieves the clinical signs and symptoms of ankylosing spondylitis at two years, shows a study published in the Annals of the Rheumatic Diseases.
Statins with TNFa Treatment Lowers LDL levels in PsA
TNF-α inhibitor treatment in PsA, RA and AS may be associated with a significant increase in total cholesterol, triglycerides and the atherogenic index. Statins with treatment lowered LDL levels.
ACR 2016 Pharma Reports for AS, Gout, PsA and RA
In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.
Measuring CVD Risk
Polish researchers writing in the journal Reumatologia outline algorithms used to assess cardiovascular disease risk in rheumatoid arthritis, PsA and AS patients.
Adalimumab-atto: It’s Indications and Key Takeaways
In this slideshow, we summarize the newly approved indications for Amgen's new biosimilar, adalimumab-atto (Amjevita) and, we highlight key points as stated by Amgen researchers.
Axial Spondyloarthritis Diagnosis Late by 10 Years
Chronic back pain may not be as it seems. Many patients suffer for years before being diagnosed with axial spondyloarthritis.
By clicking Accept, you agree to become a member of the UBM Medica Community.